Regulatory Updates
🌏 NMPANMPA news and analysis for pharmaceutical BD, investment, and market access
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 1–12 of 87 articles
Quick answer
NovaPharmaNews Regulatory Updates hub for NMPA covers 87 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.
PMDA approves ENHERTU for HER2-low breast cancer in Japan
Drug Discovery Technology Market Size Tops USD 80.27 Billion by 2035
Clinical Trials Outsourcing Market Size: 2026-2034 Growth Outlook
TGA Australia drug approval pharmaceutical: what the regulator is
PMDA Regulatory Updates: New Orphan Drug Portal and ASEAN Symposium Open
NMPA China FDA Drug Approval: 2026 Pathways, Timelines & Impact
ASCO26: Revolution's Daraxonrasib Phase III Data Reshapes Pancreatic Cancer Odds
Vietnam and India Reshape Middle Power Diplomacy: Market Analysis for Pharma
NMPA Drug Approvals Surge in 2025: Record 61 First Global Approvals Signal Accelerated Market Access
A Decade of AI Medical Device Regulation: Key Updates for Pharma
Building a Smarter Medical Devices Ecosystem in India: Regulatory Updates
Cell and Gene Therapy Approvals in China: Latest Regulatory Updates
Frequently asked questions
How often is this topic updated?
New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.
Where does this coverage come from?
Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.